China's Impact Therapeutics raises $10m Series B round

China's Impact Therapeutics raises $10m Series B round

23 February, 2016

China drug development China medical care China Summit Capital Guangzhou Yuexiu Industrial Investment Fund Haibang Ventures.Impact funding Impact Therapeutics Sungent Bioventure

Printed by Unregistered user on Fri, 12 Dec 2025 17:16:23 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

JD.com pledges $3.12b housing support for delivery riders

Venture Capital

HongShan-backed GenAI startup DIP raises nearly $50m Series D funding